Cited by 168Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response

Post, Robert M.·1978·Archives of General Psychiatry

DOI 10.1001/archpsyc.1978.01770290091008

Open this paper in CoChat — free account

Abstract

Piribedil, a compound that stimulates dopamine receptors in a relatively specific fashion, was administered to 11 hospitalized depressed patients. The dopamine agonist significantly decreased rapid eye movement (REM) sleep and percent REM sleep and increased REM latency. Piribedil decreased the probenecid-induced accumulation of the dopamine metabolite homovanillic acid (HVA) in CSF. A range of mild to moderate antidepressant effects was noted; one patient worsened and one developed recurrent manic episodes. The degree of improvement in depression was negatively correlated with pretreatment values of HVA in CSF (r = -.66, P less than .05). These data suggest that the heterogeneity of clinical response may be related to biological differences in depressed patients and that those with low initial dopaminergic function respond best to increased dopamine receptor stimulation.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1978.01770290091008

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,166
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
Methods for Reliable Longitudinal Observation of Behavior
Bunney, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
REM latency: a psychobiologic marker for primary depressive disease.
Dj, K. (1976) · PubMed · Cited by 443
Clinical criteria for psychiatric diagnosis and DSM-III
Spitzer, R. L., Endicott, J., & Robins, E. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.11.1187 · Cited by 402

Show all 65 references

Sorted by citations

The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 865
Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Cerebral Metabolic Rates for Glucose in Mood Disorders
Baxter, L. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790280019002 · Cited by 602
Magnetic Resonance Imaging of the Caudate Nuclei in Depression: Preliminary Observations
Krishnan, K. R. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070047007 · Cited by 365
Dopamine and depression
Brown, A. S., & Gershon, S. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245227 · Cited by 359
Role of the dopaminergic system in depression
Kapur, S., & Mann, J. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 350
Conditioning and Sensitisation in the Longitudinal Course of Affective Illness
Post, R. M., Rubinow, D. R., & Ballenger, J. C. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.2.191 · Cited by 337
Self-citation
Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system
Keck, M. E., Welt, T., Müller, M. B., Erhardt, A., Ohl, F., Toschi, N., Holsboer, F., & Sillaber, I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00069-2 · Cited by 312
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois, S., Lhommée, E., Klinger, H., Ardouin, C., Schmitt, E., Bichon, A., Kistner, A., Castrioto, A., Xie, J., Fraix, V., et al. (2013) · Brain : a journal of neurology · doi:10.1093/brain/awt067 · Cited by 258
Dopamine and depression: A review of recent evidence. I. Empirical studies
Willner, P. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90005-x · Cited by 273
CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa
Gerner, R. H., & Hare, T. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.8.1098 · Cited by 259
Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats
Moreau, J., Jenck, F., Martin, J. R., Mortas, P., & Haefely, W. E. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90035-7 · Cited by 250
The role of dopamine in mood disorders
Diehl, D. J., & Gershon, S. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90007-d · Cited by 216
Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals
Gerner, R. H., Post, R. M., Gillin, C., & Bunney, W. E. (1979) · Journal of Psychiatric Research · doi:10.1016/0022-3956(79)90004-9 · Cited by 206
Self-citation
Adenosine A 2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A 2A receptor knockout mice
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J., & Vaugeois, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704240 · Cited by 204
Dopaminergic-based pharmacotherapies for depression
Papakostas, G. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.002 · Cited by 171
Dynamics of the dopaminergic system as a key component to the understanding of depression
Yadid, G., & Friedman, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 160
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis
López‐León, S., Croes, E. A., Sayed‐Tabatabaei, F. A., Claes, S. J., Broeckhoven, C. V., & van Duijn, C. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.030 · Cited by 156
β-Endorphin
Gerner, R. H. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780190040005 · Cited by 154
Increased Intracranial Self-Stimulation in Rats After Long-Term Administration of Desipramine
Fibiger, H. C., & Phillips, A. G. (1981) · Science · doi:10.1126/science.7197394 · Cited by 154
Biogenic amine hypothesis of affective disorders
Garver, D. L., & Davis, J. M. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90208-x · Cited by 148
Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole
Willner, P., Lappas, S., Cheeta, S., & Muscat, R. (1994) · Psychopharmacology · doi:10.1007/bf02245568 · Cited by 142
Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide
Post, R. M., Jimerson, D. C., Bunney, W. E., & Goodwin, F. K. (1980) · Psychopharmacology · doi:10.1007/bf00431272 · Cited by 136
Self-citation
Stressor-induced anhedonia in the mesocorticolimbic system
Zacharko, R. M., & Anisman, H. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80032-6 · Cited by 135
Neuroleptic dysphoria: towards a new synthesis
Voruganti, L. N. P., & Awad, A. G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1648-y · Cited by 131
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott-Hazard, S., Morgan, D., DeLeon-Jones, F. A., Overstreet, D. H., & Janowsky, D. S. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 124
Adenosine A2Areceptors and depression
Yacoubi, M. E., Costentin, J., & Vaugeois, J. (2003) · Neurology · doi:10.1212/01.wnl.0000095220.87550.f6 · Cited by 122
Effect of antidepressants on striatal and accumbens extracellular dopamine levels
Ichikawa, J., & Meltzer, H. Y. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00264-l · Cited by 121
Akinesia: A syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia
Bermanzohn, P. C., & Siris, S. G. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90045-r · Cited by 119
Repetitive Transcranial Magnetic Stimulation
Padberg, F., & ller, H.-J. R. M. (2003) · CNS Drugs · doi:10.2165/00023210-200317060-00002 · Cited by 116
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
Roy, A., Pickar, D., Linnoila, M., Doran, A. R., Ninan, P. T., & Paul, S. M. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90065-4 · Cited by 113
Growth Hormone and Prolactin Response to Apomorphine in Schizophrenia and the Major Affective Disorders
Meltzer, H. Y. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790160098013 · Cited by 113
Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression
Saletu, B., Brandstätter, N., Stamenkovic, M., Anderer, P., Semlitsch, H. V., Grünberger, J., Linzmayer, L., Decker, K., Binder, G., Metka, M., et al. (1995) · Psychopharmacology · doi:10.1007/bf02246261 · Cited by 105
Recent developments in anxiety, stress, and depression
File, S. E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02175-2 · Cited by 103
Involvement of Serotonin and Dopamine in the Mechanism of Action of Novel Antidepressant Drugs
Bonhomme, N., & Esposito, E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00005 · Cited by 99
The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson???s Disease
Gallagher, D. A., & Schrag, A. E. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00003 · Cited by 97
D-Amphetamine in obsessive-compulsive disorder
Insel, T. R., Hamilton, J. A., Guttmacher, L. B., & Murphy, D. L. (1983) · Psychopharmacology · doi:10.1007/bf00436159 · Cited by 90
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
Millan, M. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.002 · Cited by 92
Cerebrospinal Fluid Studies of Neurotransmitter Function in Manic and Depressive Illness
Post, R. M., Ballenger, J. C., & Goodwin, F. K. (1980) · Springer eBooks · doi:10.1007/978-1-4684-1039-6_47 · Cited by 88
Self-citation
Fluoxetine treatment of depression
Mårtensson, B., Nyberg, S., Toresson, G., Brodin, E., & Bertilsson, L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb10307.x · Cited by 86
The role of prolactin in andrology: what is new?
Rastrelli, G., Corona, G., & Maggi, M. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9322-3 · Cited by 87
Antidepressant-Like Effect of D2/3 Receptor-, but not D4 Receptor-Activation in the Rat Forced Swim Test
Basso, A. M., Gallagher, K. B., Bratcher, N. A., Brioni, J. D., Moreland, R. B., Hsieh, G. C., Drescher, K. U., Fox, G. B., Decker, M. W., & Rueter, L. E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300677 · Cited by 79
Bupropion in Depression
Golden, R. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260047006 · Cited by 78
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls
Bowden, C., Theodorou, A. E., Cheetham, S. C., Lowther, S., Katona, C., Crompton, M. R., & Horton, R. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01460-6 · Cited by 76
Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine
Serra, G., Argiolas, A., Fadda, F., Melis, M. R., & Gessa, G. L. (1981) · Psychopharmacology · doi:10.1007/bf00429217 · Cited by 76
Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression
Kasper, S. F., Sack, D. A., Wehr, T. A., Kick, H. A., Voll, G., & Vieira, A. H. G. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90137-0 · Cited by 74
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
Inoue, T., Tsuchiya, K., Miura, J., Sakakibara, S., Denda, K., Kasahara, T., & Koyama, T. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00666-4 · Cited by 73
Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study
Masini, C. V., Holmes, P. V., Freeman, K. G., Maki, A. C., & Edwards, G. L. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.01.003 · Cited by 71
A double–blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression
Åberg‐Wistedt, A. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00914.x · Cited by 71
The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: A preliminary report
Gillin, J. C., Pulvirenti, L., Withers, N. W., Golshan, S., & Koob, G. F. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90019-1 · Cited by 67
Bromocriptine treatment of depressive disorders
Nordin, C., Siwers, B., & Bertilsson, L. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00758.x · Cited by 66
Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity
Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., & Bloom, F. E. (1982) · Brain Research · doi:10.1016/0006-8993(82)90282-7 · Cited by 67
Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation
Carlson, P. J., Merlock, M., & Suppes, T. M. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00132.x · Cited by 63
Slowness of movement in melancholic depression
Sachdev, P. S., & Aniss, A. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91256-4 · Cited by 60
The anatomy of melancholia: does frontal-subcortical pathophysiology underpin its psychomotor and cognitive manifestations?
Austin, M., & Mitchell, P. B. (1995) · Psychological Medicine · doi:10.1017/s0033291700034929 · Cited by 59
Depression-Dependent Dyskinesias in Two Cases of Manic-Depressive Illness
Cutler, N. R., Post, R. M., Rey, A. C., & Bunney, W. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104303041807 · Cited by 59
Self-citation
The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake
Viana, A. F., do-Rego, J.-C., von Poser, G. L., Ferraz, A. D. B. F., Heckler, A. P. M., Costentin, J., & Rates, S. M. K. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.002 · Cited by 58
Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
Rocca, P., Leo, C. D., Eva, C. E., Marchiaro, L., Milani, A. M., Musso, R., Ravizza, L., Zanalda, E., & Bogetto, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00253-1 · Cited by 58
Bipolar depression: treatment options.
Yatham, L. N., Kusumakar, V., Parikh, S. V., Haslam, D. R. S., Matte, R., Sharma, V., & Kennedy, S. H. (1997) · PubMed · Cited by 54
Activity and acceptability of piribedil in Parkinson's disease: a multicentre study
Rondot, P., & Ziegler, M. (1992) · Journal of Neurology · doi:10.1007/bf00819564 · Cited by 54
Don't leave the “psych” out of neuropsychology
Gray, J. A., & Baruch, I. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047579 · Cited by 54
COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder
Soeiro‐de‐Souza, M. G., Machado‐Vieira, R., Bio, D. S., do Prado, C. M., & Moreno, R. A. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01030.x · Cited by 51
Cerebrospinal fluid GABA in normals and patients with affective disorders
Post, R. M., Ballenger, J. C., Hare, T. A., Goodwin, F. K., Lake, C. R., Jimerson, D. C., & Bunney, W. E. (1980) · Brain Research Bulletin · doi:10.1016/0361-9230(80)90124-0 · Cited by 50
Self-citation
Treatment of Acute Bipolar Depression: A Review of the Literature
Srisurapanont, M., Yatham, L. N., & Zis, A. P. (1995) · The Canadian Journal of Psychiatry · doi:10.1177/070674379504000906 · Cited by 49
No evidence of association between dopamine D4 receptor variants and bipolar affective disorder
Lim, L. C.-C., Nöthen, M. M., Körner, J., Rietschel, M., Castle, D. J., Hunt, N., Propping, P., Murray, R. M., & Gill, M. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540314 · Cited by 49
A review of acute treatments for bipolar depression
Silverstone, P. H., & Silverstone, T. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00001 · Cited by 48
Postpartum and Depression Status are Associated With Lower [11C]raclopride BPND in Reproductive-Age Women
Moses‐Kolko, E. L., Price, J. C., Wisner, K. L., Hanusa, B. H., MELTZER, C. C., Berga, S. L., Grace, A. A., di Scalea, T. L., Kaye, W. H., Becker, C. R., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.328 · Cited by 49
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors
Brocco, M., Dekeyne, A., Papp, M., & Millan, M. J. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000236267.41806.5b · Cited by 49
Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals
Gerner, R. H., van Kammen, D. P., & Ninan, P. T. (1985) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(85)90181-2 · Cited by 46
Higher CSF Levels of HVA and 5-HIAA in Delusional Compared to Nondelusional Depression
Åberg-Wistedt, A. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320097015 · Cited by 46
Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: Clinical and theoretical implications
Post, R. M., Uhde, T. W., Rubinow, D. R., & Huggins, T. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90045-x · Cited by 45
Self-citation
Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment
Douarin, C. L., Oblin, A., Fage, D., & Scatton, B. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90030-4 · Cited by 45
Aggression in Hyperactive Boys: Response to d-Amphetamine
AMERY, B., Minichiello, M. D., & Brown, G. L. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60505-7 · Cited by 45
Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects
Jimerson, D. C., Cutler, N. R., Post, R. M., Rey, A. C., Gold, P. W., Brown, G. M., & Bunney, W. E. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90113-6 · Cited by 39
Self-citation
Antidepressant drug development: Focus on triple monoamine reuptake inhibition
Lane, R. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553252 · Cited by 41
Piribedil: Behavioural, neurochemical and clinical profile of a dopamine agonist
Dourish, C. T. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90085-4 · Cited by 36
Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity
Vaugeois, J., Pouhé, D., Zuccaro, F., & Costentin, J. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02131-0 · Cited by 36
The relevance of feedforward loops
Cools, A. R. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0004752x · Cited by 35
Depression in Parkinson's Disease
Murray, J. B. (1996) · The Journal of Psychology · doi:10.1080/00223980.1996.9915039 · Cited by 34
Searching for a technology of behavior
Kolb, B. E., Jacobs, W. J., & Petrie, B. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047610 · Cited by 34
Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression
Gründer, G., Wetzel, H., Hammes, E., & Benkert, O. (1993) · Psychopharmacology · doi:10.1007/bf02257418 · Cited by 33
Effect of sleep deprivation on dopamine receptor function in normal subjects
Lal, S., Thavundayil, J., Nair, N. P. V., Etienne, P. E., Rastogi, R., Schwartz, G. J., Pulman, J., & Guyda, H. J. (1981) · Journal of Neural Transmission · doi:10.1007/bf01254912 · Cited by 33
Trajectories of depressive symptoms, dopamine D2 and D4 receptors, family socioeconomic status and social support in adolescence and young adulthood
Guo, G., & Tillman, K. H. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32831219b6 · Cited by 31
Dopaminergic Effects of Carbamazepine
Post, R. M. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040102014 · Cited by 29
Self-citation
DOPAMINERGIC AGENTS IN AFFECTIVE ILLNESS: STUDIES WITH PIRIBEDIL, AMPHETAMINE, AND PIMOZIDE
Post, R. M., Jimerson, D. C., Victor, I. R., Goodwin, F. K., Silberman, E. K., & Bunney, W. E. (1979) · Elsevier eBooks · doi:10.1016/b978-1-4832-8363-0.50584-x · Cited by 29
Self-citation
Central monoamine metabolism in depressions. II. Catecholamines and related compounds
van Praag, H. M. (1980) · Comprehensive Psychiatry · doi:10.1016/0010-440x(80)90063-2 · Cited by 27
Does unilateral dopamine deficit contribute to depression?
Barber, J. P., Tomer, R., Sroka, H., & Myslobodsky, M. S. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90035-6 · Cited by 26
Alaproclate a novel antidepressant?
Åberg‐Wistedt, A., Alvariza, M. C. D., Bertilsson, L., Malmgren, R., & Wachtmeister, H. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01282.x · Cited by 26
The role of dopaminergic agents in improving quality of life in major depressive disorder
IsHak, W. W., Davis, M. C., Jeffrey, J. K., Balayan, K., Pechnick, R. N., Bagot, K. S., & Rapaport, M. H. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0076-z · Cited by 25
Treatment of Bipolar Depression
Dubovsky, S. L. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.02.003 · Cited by 25
Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience
Evidente, V. G. H., Esteban, R. P., Domingo, F. M., Carbajal, L. O., & Parazo, M. A. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00096-8 · Cited by 22
Reduced presynaptic dopamine receptor density after chronic antidepressant treatment in rats
Lee, T., & Tang, S. W. (1982) · Psychiatry Research · doi:10.1016/0165-1781(82)90059-2 · Cited by 22
Effects of bromocriptine and α-flupenthixol on sleep in REM sleep deprived rats
Radulovacki, M. G., Wojcik, W. J., & Fornal, C. A. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90256-x · Cited by 21
Hormone replacement therapy and vigilance
Saletu, B., Anderer, P., Gruber, D. M., Metka, M., Huber, J. C., & Saletu-Zyhlarz, G. M. (2002) · Maturitas · doi:10.1016/s0378-5122(02)00201-3 · Cited by 20
Binding of imipramine to plasma protein and to brain tissue: Relationship to CSF tricyclic levels in man
Potter, W. Z., Muscettola, G., & Goodwin, F. K. (1979) · Psychopharmacology · doi:10.1007/bf00429700 · Cited by 20
A double‐blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression
Åberg‐Wistedt, A., Ross, S. B., Jostell, K. ‐., & Sjöquist, B. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00915.x · Cited by 20
Evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the antidepressant‐like action of riparin III obtained from Aniba riparia (Nees) Mez (Lauraceae) in mice
de Melo, C. T. V., de Carvalho, A. M. R., Moura, B. A., Teixeira, C. P. L., Vasconcelos, L. F., Feitosa, M. L., de Oliveira, G. V., Barbosa‐Filho, J. M., Gutierrez, S. J. C., Fonteles, M. M. D. F., et al. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00968.x · Cited by 19

Authors: Post, R. M.
Corresponding author: Post, Robert M.
ORCID: Post, Robert M.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1978-05-01
Volume: 35
Issue: 5
Pages: 609
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1978.01770290091008
OpenAlex: W1981234468
Cited by: 168
References: 65
Citations by year: 2023: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 4
FWCI: 7.95
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: piribedil, dopamine agonists, depression, REM sleep, REM latency, homovanillic acid, cerebrospinal fluid, probenecid, antidepressant response, manic episodes, dopaminergic activity, individual differences in treatment response
MeSH terms: Adult, Bipolar Disorder, Clinical Trials as Topic, Depression, Double-Blind Method, Female, Homovanillic Acid, Humans, Male, Middle Aged, Phenylacetates, Piperazines, Piribedil, Psychiatric Status Rating Scales, Receptors, Dopamine, Sleep, REM

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks